Prognostic evaluation of severe sepsis and septic shock: Procalcitonin clearance vs[delta]Sequential Organ Failure Assessment
Purpose The purpose of the study is to compare the clearance of procalcitonin (PCT-c) in the first 24 and 48 hours of treatment of severe sepsis and septic shock with another early prognostic marker represented by the 48-hourδSequential Organ Failure Assessment (SOFA). Materials and methods Prospect...
Gespeichert in:
Veröffentlicht in: | Journal of critical care 2015-02, Vol.30 (1), p.219.e9 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose The purpose of the study is to compare the clearance of procalcitonin (PCT-c) in the first 24 and 48 hours of treatment of severe sepsis and septic shock with another early prognostic marker represented by the 48-hourδSequential Organ Failure Assessment (SOFA). Materials and methods Prospective, observational cohort study conducted in a general intensive care unit including patients with severe sepsis and septic shock. The PCT-c was determined at the diagnosis of sepsis and after 24 and 48 hours. The SOFA score was determined at the time of intensive care unit admission and after 48 hours. Results One hundred thirty adult patients with severe sepsis and septic shock were studied over an 18-month period. The 24- and 48-hour PTC-c scores were significantly higher in survivors (P< .0001). In nonsurvivors, the initial SOFA was significantly higher, and the 48-hourδSOFA was significantly smaller (P= .01). The area under the receiver operating characteristic curve was 0.68 forδSOFA and 0.76 for 24- and 48-hour PCT-c. Conclusions The 48-hourδSOFA score and the clearance of 24- and 48-hour PCT are useful markers of prognosis in patients with severe sepsis and septic shock. A decrease in PCT-c in the first 24 hours of treatment should prompt the reassessment of the appropriateness and adequacy of treatment. |
---|---|
ISSN: | 0883-9441 1557-8615 |
DOI: | 10.1016/j.jcrc.2014.08.018 |